Canada consults on submission of device licences in non-STED format
This article was originally published in RAJ Devices
Health Canada has issued for consultation revised guidance for medical device manufacturers that choose not to submit applications for Class III and Class IV device licence applications and licence amendment in the STED format – the global submission document1.
You may also be interested in...
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Sixty-nine guidance documents have been posted on the tracker since its last update.
A UK regulator with the MHRA is concerned that bioanalytical laboratories are not being given enough time to do their job properly by drug companies under pressure to ensure their clinical trials remain on schedule.
The UK regulator is expecting a rise in amendments and deviations to ongoing clinical investigations of medical devices due to the COVID-19 pandemic and has issued advice on how companies should manage these.